Journal of New Developments in Chemistry

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

New Developments in Chemistry-Medicinal Chemistry-Mohammed El-Gamal

Korea, Republic Of

Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea; 
University of Science and Technology (UST), Daejeon, Republic of Korea.

Send an Email

Mohammed El-Gamal

Address:

<39-1> Hawolgok-dong, Seongbuk-ku, Seoul, Republic of Korea.
Korea Institute of Science and Technology (KIST),
Center for Biomaterials, Lab#2222.

Research Interests:

  • Medicinal Chemistry
  • Drug Design and Synthesis
  • Biological Screening of Novel Therapeutics
  • Pharmacokinetics & Pharmacodynamics
  • Molecular Modeling

Biography:

  • Mohammed I. El-Gamal, Ph.D. got his B.Sc. degree in pharmaceutical Sciences at the Faculty of Pharmacy, University of Mansoura, Egypt in 2003 with "Excellent with honor" grade, first achiever. 
  • Then he received his M.Sc. degree in medicinal chemistry from the same college. 
  • He got his Ph.D. degree in medicinal chemistry in August 2012 from Korea University of Science and Technology, Korea Institute of Science and Technology (KIST), Republic of Korea. 
  • After that, he worked as a star postdoctoral fellow at KIST and assistant professor of medicinal chemistry at the Faculty of Pharmacy, University of Mansoura, Egypt. 
  • Mohammed I. El-Gamal, Ph.D. is the author of more than 50 publications in highly reputed journals. 
  • He got 3 patents, and presented more than 36 posters and 8 oral presentations in many international conferences in The Republic of Korea, United Arab Emirates, USA, Japan, The Netherlands, and Austria. 
  • He has peer-review more than 50 articles. 
  • And he has been an editorial board member in more than 13 international journals. He has been also a member of the Asian Council of Science Editors (ACSE). 
  • Mohammed I. El-Gamal, Ph.D. and his group have developed a new more efficient prodrug of Olmesartan (antihypertensive agent) which has been marketed in the Republic of Korea. 
  • And he is interested in anticancer, anti-inflammatory, and antimicrobial drug development.